300 related articles for article (PubMed ID: 18571403)
1. Synthesis and cytotoxic activity of benzopyran-based platinum(II) complexes.
Gupta A; Mandal SK; Leblanc V; Descôteaux C; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2008 Jul; 18(14):3982-7. PubMed ID: 18571403
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 2,3,4-triarylbenzopyran derivatives as SERM and therapeutic agent for breast cancer.
Kumar S; Deshpande S; Chandra V; Kitchlu S; Dwivedi A; Nayak VL; Konwar R; Prabhakar YS; Sahu DP
Bioorg Med Chem; 2009 Oct; 17(19):6832-40. PubMed ID: 19740667
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 17beta-estradiol-linked platinum(II) complexes and their cytocidal activity on estrogen-dependent and -independent breast tumor cells.
Perron V; Rabouin D; Asselin E; Parent S; C-Gaudreault R; Bérubé G
Bioorg Chem; 2005 Feb; 33(1):1-15. PubMed ID: 15668178
[TBL] [Abstract][Full Text] [Related]
4. Improved synthesis of unique estradiol-linked platinum(II) complexes showing potent cytocidal activity and affinity for the estrogen receptor alpha and beta.
Descôteaux C; Leblanc V; Bélanger G; Parent S; Asselin E; Bérubé G
Steroids; 2008 Oct; 73(11):1077-89. PubMed ID: 18572212
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
Coley HM; Sarju J; Wagner G
J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxicity of cis-dichloroplatinum (II) complexes of (1S,3S)-1,2,3,4-tetrahydroisoquinolines.
Xu G; Yan Z; Wang N; Liu Z
Eur J Med Chem; 2011 Jan; 46(1):356-63. PubMed ID: 21144623
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: a quantitative structure-activity relationship approach.
Monti E; Gariboldi M; Maiocchi A; Marengo E; Cassino C; Gabano E; Osella D
J Med Chem; 2005 Feb; 48(3):857-66. PubMed ID: 15689170
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship of novel antitumoral platinum xanthate complexes.
Friebolin W; Schilling G; Zöller M; Amtmann E
J Med Chem; 2004 Apr; 47(9):2256-63. PubMed ID: 15084124
[TBL] [Abstract][Full Text] [Related]
9. Enantiomerically pure [1, 2-diamino-1-(4-fluorophenyl)butane]platinum(II) complexes: synthesis and antitumor activity against MCF-7 and MDA-MB 231 breast cancer and LnCaP/FGC prostate cancer cell lines.
Dullin A; Dufrasne F; Gelbcke M; Gust R
Arch Pharm (Weinheim); 2004 Dec; 337(12):654-67. PubMed ID: 15597399
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity of enantiomerically pure [1,2-diamino-1-(4-fluorophenyl)-3-methylbutane]platinum(II) complexes.
Dullin A; Dufrasne F; Gelbcke M; Gust R
ChemMedChem; 2006 Jun; 1(6):644-53. PubMed ID: 16892405
[TBL] [Abstract][Full Text] [Related]
11. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and cytotoxicity of a series of estrogen-tethered platinum(IV) complexes.
Barnes KR; Kutikov A; Lippard SJ
Chem Biol; 2004 Apr; 11(4):557-64. PubMed ID: 15123250
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 17beta-estradiol-platinum(II) hybrid molecules showing cytotoxic activity on breast cancer cell lines.
Provencher-Mandeville J; Descôteaux C; Mandal SK; Leblanc V; Asselin E; Bérubé G
Bioorg Med Chem Lett; 2008 Apr; 18(7):2282-7. PubMed ID: 18356047
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticancer activity of novel tetralin-6-ylpyridine and tetralin-6-ylpyrimidine derivatives.
Amin KM; El-Zahar MI; Anwar MM; Kamel MM; Mohamed MH
Acta Pol Pharm; 2009; 66(3):279-91. PubMed ID: 19645328
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and antitumor activities of triazacyclodecane and its platinum (II) complex].
Zhou SS; Zhang QY; Qin K; Lu CH; Xie FX
Yao Xue Xue Bao; 2008 May; 43(5):490-4. PubMed ID: 18717336
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxic effect, and structure-activity relationship of Pd(II) complexes with coumarin derivatives.
Budzisz E; Małecka M; Lorenz IP; Mayer P; Kwiecień RA; Paneth P; Krajewska U; Rózalski M
Inorg Chem; 2006 Nov; 45(24):9688-95. PubMed ID: 17112264
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro cytotoxicity of novel hydrophilic chiral 2-alkoxy-1,4-butanediamine platinum (II) complexes.
Zhu H; Cui K; Wang L; Gou S
Bioorg Med Chem Lett; 2005 Nov; 15(22):4936-43. PubMed ID: 16169720
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic activity of metal complexes of biogenic polyamines: polynuclear platinum(II) chelates.
Teixeira LJ; Seabra M; Reis E; da Cruz MT; de Lima MC; Pereira E; Miranda MA; Marques MP
J Med Chem; 2004 May; 47(11):2917-25. PubMed ID: 15139770
[TBL] [Abstract][Full Text] [Related]
20. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
